摘要
研究了试管内无细胞毒性浓度的Ge-132抑制EB病毒转化人脐血B淋巴细胞的作用。结果表明,Ge-132(50~200mg/L)能明显抑制EB病毒转化人脐血B淋巴细胞,抑制率为951%~4754%(P<001)。基于EB病毒与鼻咽癌密切相关,本结果提示,Ge-132可能有助于鼻咽癌和EB病毒相关的疾病的预防和治疗。
The inhibition of Ge-132 of non-toxic doses on transformation in B lymphocytes from human umbilical cord blood(BL)with Epstein-Barr virus(EBV)in vitro was studied.It was found that transformation effects of BL with EBV was markedly inhibited by Ge-132(50~200 mg/L).The inhibition rates of BL reansformation were 9 51%~47 54%.EBV is associated with napspharyngeal carcinoma(NPC).The results suggest that Ge-132 may help protect against and treat NPC and the diseases associated with EBV.
出处
《广东微量元素科学》
CAS
1999年第8期18-20,共3页
Trace Elements Science
关键词
EB病毒
淋巴细胞转化
锗-132
鼻咽癌
Carboxy ethyl germanium sesquioxide(Ge-132),Epstein-Barr virus(EBV),Lymphocyte transformation.